Annette Lam

4PUBLICATIONS
12CO-AUTHORS
Disease surveillanceNanomedicineMedical virologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 25, 2022
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.

Angela Dispenzieri, Jeffrey Zonder, James Hoffman

|Nov 06, 2019
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison.

Maria-Victoria Mateos, Jesus San-Miguel, Hartmut Goldschmidt

|Nov 06, 2019
A matching-adjusted indirect treatment comparison (MAIC) of daratumumab-bortezomib-melphalan-prednisone (D-VMP) versus lenalidomide-dexamethasone continuous (Rd continuous), lenalidomide-dexamethasone 18 months (Rd 18), and melphalan-prednisone-thalidomide (MPT).

Meletios A Dimopoulos, Michele Cavo, Maria-Victoria Mateos

|May 06, 2017
Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison.

Saad Z Usmani, Joris Diels, Tetsuro Ito

Pageof 1

Frequent Collaborators

2 joint publications

Meletios A Dimopoulos

2 joint publications

Maria-Victoria Mateos

2 joint publications

Bart Heeg

1 joint publications

Jesus San-Miguel